Pascal and Francis Bibliographic Databases


Permanent link :


Selection :

Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in antiretroviral-naive subjects: 48-week results

MURPHY, Robert L; SANNE, Ian; CAHN, Pedro; PHANUPHAK, Praphan; PERCIVAL, Lisa; KELLEHER, Thomas; GIORDANO, Michael

AIDS (London). 2003, Vol 17, Num 18, pp 2603-2614, 12 p ; ref : 54 ref

Scientific domain
Immunology, immunopathology, allergology; Microbiology, infectious diseases
Lippincott Williams & Wilkins, Hagerstown, MD
Publication country
United States
Document type
Author keyword
atazanavir cardiovascular disease highly active antiretroviral therapy hyperlipidemia protease inhibitors
Keyword (fr)
Antiviral Appareil circulatoire pathologie Association médicamenteuse Atazanavir Chimiothérapie Conception Dose Efficacité Essai clinique Exploration immunologique Extrémité Homme Hyperlipémie Inhibiteur protease Lamivudine Lipide Lymphocyte T Méthode Nelfinavir Numération RNA SIDA Stavudine Virus HIV1 Antigène CD4 Antirétroviral Protocole HAART Traitement initial Analogue nucléoside Appareil digestif pathologie Didésoxynucléoside Dyslipémie Enzyme Hydrolases Immunodéficit Immunopathologie Infection Inhibiteur enzyme Inhibiteur reverse transcriptase Intestin pathologie Lentivirus Métabolisme pathologie Nucleotidyltransferases Peptidases Pyrimidine nucléoside RNA-directed DNA polymerase Retroviridae Transferases Vaisseau sanguin pathologie Virose Virus immunodéficience humaine Virus
Keyword (en)
Antiviral Cardiovascular disease Drug combination Atazanavir Chemotherapy Design Dose Efficiency Clinical trial Immunological investigation End Human Hyperlipemia Protease inhibitor Lamivudine Lipids T-Lymphocyte Method Nelfinavir Numeration RNA AIDS Stavudine HIV-1 virus Nucleosidic analog Digestive diseases Dideoxynucleoside Dyslipemia Enzyme Hydrolases Immune deficiency Immunopathology Infection Enzyme inhibitor Reverse transcriptase inhibitor Intestinal disease Lentivirus Metabolic diseases Nucleotidyltransferases Peptidases Pyrimidine nucleoside RNA-directed DNA polymerase Retroviridae Transferases Vascular disease Viral disease Human immunodeficiency virus Virus
Keyword (es)
Antiviral Aparato circulatorio patología Asociación medicamentosa Atazanavir Quimioterapia Diseño Dosis Eficacia Ensayo clínico Análisis inmunológico Extremidad Hombre Hiperlipemia Inhibidor proteasa Lamivudina Lípido Linfocito T Método Nelfinavir Numeración RNA SIDA Estavudina HIV-1 virus Análogo nucleósido Aparato digestivo patología Didesoxinucleósido Dislipemia Enzima Hydrolases Inmunodeficiencia Inmunopatología Infección Inhibidor enzima Inhibitor reverse transcriptase Intestino patología Lentivirus Metabolismo patología Nucleotidyltransferases Peptidases Pirimidina nucleósido RNA-directed DNA polymerase Retroviridae Transferases Vaso sanguíneo patología Virosis Human immunodeficiency virus Virus
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents

002 Biological and medical sciences / 002B Medical sciences / 002B22 Metabolic diseases / 002B22A Disorders of blood lipids. Hyperlipoproteinemia

Metabolic diseases Pharmacological treatments
INIST identifier

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web